Brazilian biotech startup, PluriCell, raises US$1 million to combat cardiovascular disease – Contxto

Mang. Const.

Brazilian biotech startup, PluriCell, raises US$1 million to combat cardiovascular disease  Contxto

Contxto – PluriCell recently raised US$1 million from Libbs Farmacêutica to continue developing its regenerative cell therapy for cardiovascular diseases.

Source: Mang. Const.